Related Experiment Videos
Neuropharmacology of 5-hydroxytryptamine1B/D receptor ligands
1Division of Neurobiology I, Pierre Fabre Research Center, Castres, France.
Pharmacology & Therapeutics
|January 1, 1994
Abstract:
In spite of a lack of compounds acting selectively at the 5-hydroxytryptamine (5-HT)1B and 5-HT1D receptor subtypes, by cross-relating the available data, this review attempts to tentatively assign behavioural and other in vivo correlates of these receptor subtypes. In addition, a summary of data from microdialysis studies is included to develop an integrated view. Finally, a suggestion is made as to the possible pathophysiological consequences of 5-HT1D receptor dysfunction in man.